Skip to Main Content

Author Details

Michael J Gough
Earle A. Chiles Research Institute, Providence Cancer Institute
1999
95
40
PMIDPaper TitleJournal TitlePublished Year
36710051Ex vivo analysis of radiation effects on tumor infiltrating immune cells using tumor explants.Methods Cell Biol2023
37496754The immunogenic radiation and new players in immunotherapy and targeted therapy for head and neck cancer.Front Oral Health2023
37244938Myeloid MyD88 restricts CD8<sup>+</sup> T cell response to radiation therapy in pancreatic cancer.Sci Rep2023
37438021The role of dendritic cells in radiation-induced immune responses.Int Rev Cell Mol Biol2023
37072485Tumor resident memory CD8 T cells and concomitant tumor immunity develop independently of CD4 help.Sci Rep2023
35952709Galunisertib plus neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer: a single-arm, phase 2 trial.Lancet Oncol2022
35691060The paradox of radiation and T cells in tumors.Neoplasia2022
35487695Fluorescent tracking identifies key migratory dendritic cells in the lymph node after radiotherapy.Life Sci Alliance2022
36106641Moving beyond the T cell synapse for combination neoadjuvant immunotherapy in head and neck cancer.J Clin Invest2022
35937775Development and therapeutic manipulation of the head and neck cancer tumor environment to improve clinical outcomes.Front Oral Health2022
36056093ICOS is upregulated on T cells following radiation and agonism combined with radiation results in enhanced tumor control.Sci Rep2022
33097963Response to radiotherapy in pancreatic ductal adenocarcinoma is enhanced by inhibition of myeloid-derived suppressor cells using STAT3 anti-sense oligonucleotide.Cancer Immunol Immunother2021
33796412Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-term survivorship in pancreatic cancer.Oncoimmunology2021
33816320Defining Immunogenic and Radioimmunogenic Tumors.Front Oncol2021
33526513Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic Cancer.Cancer Res2021
34381163Listeria monocytogenes-infected human monocytic derived dendritic cells activate Vγ9Vδ2 T cells independently of HMBPP production.Sci Rep2021
34221953Explant Modeling of the Immune Environment of Head and Neck Cancer.Front Oncol2021
33968757The Dynamic Entropy of Tumor Immune Infiltrates: The Impact of Recirculation, Antigen-Specific Interactions, and Retention on T Cells in Tumors.Front Oncol2021
34194619A platform for locoregional T-cell immunotherapy to control HNSCC recurrence following tumor resection.Oncotarget2021
32381295Using Preclinical Data to Design Combination Clinical Trials of Radiation Therapy and Immunotherapy.Semin Radiat Oncol2020
32733475Characterization of a Novel Compound That Stimulates STING-Mediated Innate Immune Activity in an Allele-Specific Manner.Front Immunol2020
32866185Transcriptional and immunohistological assessment of immune infiltration in pancreatic cancer.PLoS One2020
32341058Dendritic Cell Maturation Defines Immunological Responsiveness of Tumors to Radiation Therapy.J Immunol2020
32311417Targeting MerTK Enhances Adaptive Immune Responses After Radiation Therapy.Int J Radiat Oncol Biol Phys2020
32355214Transcriptional Upregulation of NLRC5 by Radiation Drives STING- and Interferon-Independent MHC-I Expression on Cancer Cells and T Cell Cytotoxicity.Sci Rep2020
32273499TGFβ suppresses CD8<sup>+</sup> T cell expression of CXCR3 and tumor trafficking.Nat Commun2020
30601871A microbial-based cancer vaccine for induction of EGFRvIII-specific CD8+ T cells and anti-tumor immunity.PLoS One2019
30798988Activating the Nucleic Acid-Sensing Machinery for Anticancer Immunity.Int Rev Cell Mol Biol2019
30726287Blockade of fibroblast activation protein in combination with radiation treatment in murine models of pancreatic adenocarcinoma.PLoS One2019
29150567Amplifying IFN-γ Signaling in Dendritic Cells by CD11c-Specific Loss of SOCS1 Increases Innate Immunity to Infection while Decreasing Adaptive Immunity.J Immunol2018
30090929Association of Immunologic Markers With Survival in Upfront Resectable Pancreatic Cancer.JAMA Surg2018
30224374Evaluation of Explant Responses to STING Ligands: Personalized Immunosurgical Therapy for Head and Neck Squamous Cell Carcinoma.Cancer Res2018
30370351Role of the immunosuppressive microenvironment in immunotherapy.Adv Radiat Oncol2018
30701017Implantable biomaterials to provide local immunotherapy following surgical resection.Oncotarget2018
29447250Correction: STING expression and response to treatment with STING ligands in premalignant and malignant disease.PLoS One2018
29725089Tumor cure by radiation therapy and checkpoint inhibitors depends on pre-existing immunity.Sci Rep2018
27501850Programmed cell death-1 blockade enhances response to stereotactic radiation in an orthotopic murine model of hepatocellular carcinoma.Hepatol Res2017
32211517The TAM family as a therapeutic target in combination with radiation therapy.Emerg Top Life Sci2017
28465426A Novel Agonist of the TRIF Pathway Induces a Cellular State Refractory to Replication of Zika, Chikungunya, and Dengue Viruses.mBio2017
28202215Erratum to 'Cytoreductive surgery for head and neck squamous cell carcinoma in the new age of immunotherapy' [Oral Oncol. 61 (2016) 166-176].Oral Oncol2017
29135982STING expression and response to treatment with STING ligands in premalignant and malignant disease.PLoS One2017
28855348Timing of PD-1 Blockade Is Critical to Effective Combination Immunotherapy with Anti-OX40.Clin Cancer Res2017
28871985Stimulating Innate Immunity to Enhance Radiation Therapy-Induced Tumor Control.Int J Radiat Oncol Biol Phys2017
27893434Neuroinflammatory and cognitive consequences of combined radiation and immunotherapy in a novel preclinical model.Oncotarget2017
27049023Stromal fibroblasts support dendritic cells to maintain IL-23/Th17 responses after exposure to ionizing radiation.J Leukoc Biol2016
26567136Radiotherapy Combined with Novel STING-Targeting Oligonucleotides Results in Regression of Established Tumors.Cancer Res2016
26614363OX40 signaling in head and neck squamous cell carcinoma: Overcoming immunosuppression in the tumor microenvironment.Oral Oncol2016
27614589Cytoreductive surgery for head and neck squamous cell carcinoma in the new age of immunotherapy.Oral Oncol2016
27602953Mertk on tumor macrophages is a therapeutic target to prevent tumor recurrence following radiation therapy.Oncotarget2016
27532020A hypofractionated radiation regimen avoids the lymphopenia associated with neoadjuvant chemoradiation therapy of borderline resectable and locally advanced pancreatic adenocarcinoma.J Immunother Cancer2016
  • 1 - 50 of 95

Recommended Authors

Amrita Basu
University of California San Francisco
Career Start Year 2018
Number of shared co-authors 0
David Mansfield
Institute of Cancer Research
Career Start Year 2013
Number of shared co-authors 1
Christiano Tanese de Souza
Ottawa Hospital Research Institute, The Ottawa Hospital
Career Start Year 2012
Number of shared co-authors 1
Anusha Kalbasi
Stanford Cancer Institute, Stanford School of Medicine
Career Start Year 2010
Number of shared co-authors 0
Davide Bedognetti
College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation
Career Start Year 2010
Number of shared co-authors 0
Jianying Zhang
City of Hope National Medical Center
Career Start Year 2009
Number of shared co-authors 0
Benjamin G Vincent
UNC School of Medicine, The University of North Carolina at Chapel Hill
Career Start Year 2008
Number of shared co-authors 0
Tori N Yamamoto
National Cancer Institute
Career Start Year 2005
Number of shared co-authors 0
Andrea Schietinger
Memorial Sloan Kettering Cancer Center
Career Start Year 2004
Number of shared co-authors 1
Gavin P Dunn
Washington University School of Medicine
Career Start Year 2002
Number of shared co-authors 0
David J Liewehr
Center for Cancer Research
Career Start Year 1999
Number of shared co-authors 0
Paola Cappello
University of Turin
Career Start Year 1998
Number of shared co-authors 0
Masaki Terabe
National Cancer Institute
Career Start Year 1997
Number of shared co-authors 0
Seunghee Kim-Schulze
Icahn School of Medicine at Mount Sinai
Career Start Year 1996
Number of shared co-authors 0
Zhiya Yu
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1995
Number of shared co-authors 0
Sacha Gnjatic
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Career Start Year 1995
Number of shared co-authors 0
Tim F Greten
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1994
Number of shared co-authors 0
Lawrence Fong
University of California san francisco
Career Start Year 1993
Number of shared co-authors 0
Firouzeh Korangy
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1992
Number of shared co-authors 0
Jonathan S Serody
The University of North Carolina School of Medicine
Career Start Year 1991
Number of shared co-authors 0
Veena Kapoor
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1991
Number of shared co-authors 0
Craig L Slingluff
University of Virginia
Career Start Year 1987
Number of shared co-authors 0
Mary L Disis
University of Washington Medicine Cancer Vaccine Institute, University of Washington
Career Start Year 1986
Number of shared co-authors 0
Silvia C Formenti
Weill Cornell Medical College
Career Start Year 1986
Number of shared co-authors 3
Jonathan Cebon
Australia Olivia Newton-John Cancer Research Institute, La Trobe University
Career Start Year 1985
Number of shared co-authors 1
Nicholas P Restifo
National Cancer Institute, National Institutes of Health (NIH)
Career Start Year 1985
Number of shared co-authors 0
Elizabeth M Jaffee
Convergence Institute, Johns Hopkins University
Career Start Year 1985
Number of shared co-authors 4
Sandra Demaria
Weill Cornell Medical College
Career Start Year 1985
Number of shared co-authors 2
Antoni Ribas
University of California Los Angeles (university of california los angeles)
Career Start Year 1972
Number of shared co-authors 0
Steven A Rosenberg
University of Colorado School of Medicine
Career Start Year 1961
Number of shared co-authors 0

Collaborators

Alan Melcher
The Institute of Cancer Research
Co-authored papers 10
Peter J Selby
College of Agriculture and Life Sciences, Cornell University
Co-authored papers 3
Marco Del Chiaro
University of Colorado
Co-authored papers 2
Benjamin Van Court
University of Colorado
Co-authored papers 2
Adam C Mueller
Sidney Kimmel Cancer Center at Thomas Jefferson University
Co-authored papers 2
Wells A Messersmith
University of Colorado Anschutz Medical Campus
Co-authored papers 2
Richard D Schulick
University of Colorado School of Medicine
Co-authored papers 2
Sana D Karam
University of Colorado School of Medicine
Co-authored papers 2
Ayman Oweida
Universite de Sherbrooke
Co-authored papers 2
Jason Williams
University of Colorado Denver
Co-authored papers 2
Jinu Abraham
Oregon Health & Science University
Co-authored papers 2
Christopher Dubay
Earle A. Chiles Research Institute, Providence Portland Medical Center
Co-authored papers 2
Victor R DeFilippis
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Co-authored papers 2
Kimberly R Jordan
University of Colorado Anschutz Medical Campus
Co-authored papers 2
Karyn A Goodman
Mount Sinai Hospital
Co-authored papers 2
Kirk C Hansen
University of Colorado Anschutz Medical Campus
Co-authored papers 2
Shilpa Bhatia
University of Colorado Denver at Anschutz Medical Campus
Co-authored papers 2
Andy Phan
University of Colorado Anschutz Medical Campus
Co-authored papers 2
Brady Bernard
Co-authored papers 2
William J Murphy
Co-authored papers 1
Matthew R G Taylor
Cardiovascular Institute, University of Colorado
Co-authored papers 1
Michael W Knitz
University of Colorado
Co-authored papers 1
Cheryl Meguid
University of Colorado
Co-authored papers 1
Michael J Dunn
Co-authored papers 1
David Lagares
Fibrosis Research Center, Massachusetts General Hospital, Harvard Medical School
Co-authored papers 1
Adrie van Bokhoven
University of Colorado Anschutz Medical Campus
Co-authored papers 1
Casey S Greene
Dartmouth College Geisel School of Medicine, Princeton University, University of Colorado Anschutz Medical Campus, University of Pennsylvania Perelman School of Medicine
Co-authored papers 1
Brisa Pe??a
Cardiovascular Institute, University of Colorado Denver Anschutz Medical Campus
Co-authored papers 1
Ilsa T Kirby
Oregon Health & Science University
Co-authored papers 1
Alec J Hirsch
Vaccine & Gene Therapy Institute, Oregon Health & Science University
Co-authored papers 1
Release 1.2